Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma

by Chen, J., Gao, C., Liu, Y., Wang, J., Zhang, J., Zhang, X., Zhao, J.
Published 2018

Diagnostic value of conventional tumor markers in young patients with pulmonary nodules

by Su, Z., Xie, B., Xu, L.
Published 2021

Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma

by Bi, X.-F, Cai, H.-Q, Cai, Y., Chang, C., Fan, Z.-Y, Feng, D., Hao, J.-J, Qi, J., Wang, M.-J, Wang, M.-R, Wei, W.-Q, Xu, X., Zhang, Y.
Published 2021

Age-stratified and gender-specific reference intervals of six tumor markers panel of lung cancer: A geographic-based multicenter study in China

by Chen, Q., Chen, Y., Huang, H., Jiang, L., Li, G., Li, M., Li, X., Li, Y., liang Xing, J., Qu, W., Wang, S., Wang, W., Yang, C., Zhang, Y., Zhou, J.
Published 2021

Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules

by Chen, H., Li, H., Liu, H., Ni, R., Wu, Y., Yang, H., Yu, Y., Zhang, G., Zhang, Y.
Published 2022

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis

by Adachi, K., Demachi-Okamura, A., Fujinaga, K., Hatooka, S., Kaneda, S., Komuro, H., Kuroda, H., Masago, K., Matsui, T., Matsushita, H., Miyai, M., Muraoka, D., Nakada, T., Nishida, R., Ohtsuka, T., Sakakura, N., Sasano, H., Shigematsu, Y., Shinohara, S., Shomura, S., Sugita, Y., Takahara, H., Takahashi, Y., Takao, M., Watanabe, F., Yamaguchi, R.
Published 2022

Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity

by Abdeljawad, T., An, H., Bernstein, H., Blagovic, K., Booty, M.G, Chong, E., Chow, J., Gonzalez, J.T, Heimann, M., Hlavaty, K.A, How, E., Jacques, M.K, Jensen, K.F, Knoetgen, H., Langer, R., Liu, S., Loughhead, S.M, Mao, S., Merino, A., Myint, M., Ozay, E.I, Pomerance, L., Pryor, O., Sharei, A., Smith, C., Stockmann, A., Subramanya, D., Talarico, L., Tian, L., Trumpfheller, C., Umaña, P., Venkitaraman, A., Vicente-Suarez, I., Volk, K., von Andrian, U.H, Yarar, D., Yee, C.
Published 2022

Development of risk prediction models for lung cancer based on tumor markers and radiological signs

by Bi, X., Chen, T., Lu, Y., Tu, Y., Wu, Y.
Published 2021

Research and discussion on the evaluation scheme of reagent lot-to-lot differences in 16 chemiluminescence analytes, established by the EP26-A guidelines of the CLSI

by Chen, J., Cheng, Y., Gao, W., He, J., Liu, M., Mo, N., Tao, R., Xie, Q., Yang, M., Zhang, C.
Published 2021

Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors

by Bell, A.T.F, Bialkowski, L., Çuburu, N., Kim, R., Lowy, D.R, Pontejo, S.M, Schiller, J.T, Sethi, S.K, Thompson, C.D
Published 2022

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

by Bachier, C., Bai, J., Batrakou, D., Blumenschein, G.R, Broad, R., Devarakonda, S., Doger de Spéville, B., Edelman, M.J, Fayngerts, S., Fracasso, P.M, Frigault, M.J, Gainor, J., Gerry, A., Govindan, R., Heymach, J.V, Holdich, T., Hyland, N., Johnson, M., Lam, V.K, Marks, D., Moreno, V., Navenot, J.-M, Norry, E., Olszanski, A.J, Pentony, M.M, Sanderson, J.P, Wolchinsky, Z.
Published 2022

Mathematical model of a personalized neoantigen cancer vaccine and the human immune system

by McGill, J.R, Messan, M.R, Nukala, U., Sauna, Z.E, Yang, H., Yogurtcu, O.N
Published 2021

A multispecies framework for modeling adaptive immunity and immunotherapy in cancer

by Cao, Y., Qi, T., Vincent, B.G
Published 2023